Viridian Therapeutics, Inc.DE

Over the past 90 days, Viridian Therapeutics (VRDN) has reported zero cyber incidents and zero red-flag 8-K filings—no bankruptcies, restatements, or officer departures detected. This clean short-term window provides limited signal; absence of recent events does not indicate absence of underlying risk. The full $49 Report extends the analysis across 12 months of SEC filings, assigns a dilution risk score based on equity raises and warrant activity, contextualizes all 8-K events, maps financing history, and flags AI-detected risk signals that short windows may miss. The full $49 Report adds structural risk scoring, 12-month event history, and forward-looking AI signals.